No consensus on the optimal palliative radiotherapy regimen for people with inoperable non-small-cell lung cancer: Abstracted from: Toy E., Macbeth F., Coles, B. et al. Palliative thoracic radiotherapy for non-small-cell lung cancer: A systematic review. American Journal of Clinical Oncology 2003;26:112–120.

References 

1. Gridelli C, Perrone F, Nelli F, et al.  Quality of life in lung cancer patients. Ann. Oncol. 2001;12:21–25
   • CrossRef
2. Clinical Practice Guidelines for the Treatment of Unresectable Non-Small-cell lung cancer. J Clin Oncol 1997; 15: 2996–3018
3. Non-Small Cell Lung Cancer Collaborative Group: Chemotherapy in NSCLC: a meta-analysis using updated data individual patients from 52 randomized clinical trials. Br Med J 1995; 311: 899–909
4. Cullen MH, Billingham LJ, Woodroffe CM, et al.  Mitomycin, ifosfamide and cisplatin in unresectable non-small-cell lung cancer: effects on survival and quality of life. J. Clin. Oncol. 1999;17:3188–3194
   • MEDLINE
5. Billingham LJ, Cullen MH. The benefits of chemotherapy in patient subgroups with unresectable non-small-cell lung cancer. Ann. Oncol. 2001;12:1671–1675
   • MEDLINE
   • CrossRef
6. The Elderly Lung Cancer Vinorelbine Italian Study Group. Effects of Vinorelbine on quality of life and survival of elderly patients with advanced non-small-cell lung cancer. J Natl Cancer Inst 1999; 91: 66–72
7. Roila F, Cortesi E. Quality of life as a primary end-point in oncology. Ann. Oncol. 2001;12:3–6
   • CrossRef
8. Tamburini M. Health-related quality of life measures in cancer. Ann. Oncol. 2001;12:7–10
   • MEDLINE
   • CrossRef